Alberta Diabetes Institute
Edmonton, Alberta, Canada
University department in Edmonton, Alberta
112 St NW, Edmonton, AB T6G 2T9
About Alberta Diabetes Institute
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
University of Alberta
6
Allergan
3
Alessandro Doria
1
GLWL Research Inc.
1
Clinical Trials at Alberta Diabetes Institute
During the past decade, Alberta Diabetes Institute conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 6 clinical trials were completed, i.e. on
average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 5 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
2014-02-01
2019-08-31
Completed
530
A Safety and Efficacy Study of Relamorelin in Diabetic Gastroparesis Study 03
2018-01-24
2020-10-30
Terminated
467
Study to Evaluate the Safety and Efficacy of Relamorelin in Participants With Diabetic Gastroparesis Study 02
2018-02-16
2020-07-16
Terminated
311
Repeatability of Blood Glucose Responses to Resistance Exercise in Type 1 Diabetes
2021-11-16
2024-02-28
Recruiting
15
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Alberta Diabetes Institute"
#1 collaborator was "Women and Children's Health Research Institute, Canada" with 2 trials as a collaborator, "Albert Einstein College of Medicine" with 1 trials as a collaborator, "BCDiabetes.Ca" with 1 trials as a collaborator, "DexCom, Inc." with 1 trials as a collaborator and "Emory University" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were
collaborators in the rest 19 trials.
Clinical Trials Conditions at Alberta Diabetes Institute
According to Clinical.Site data, the most researched conditions in "Alberta Diabetes Institute" are
"Type 1 Diabetes" (4 trials), "Gastroparesis" (3 trials), "Diabetes Mellitus" (2 trials), "Coronary Artery Disease" (1 trials) and "Diabetic Nephropathies" (1 trials). Many other conditions were trialed in "Alberta Diabetes Institute" in a lesser frequency.
Clinical Trials Intervention Types at Alberta Diabetes Institute
Most popular intervention types in "Alberta Diabetes Institute" are "Drug" (5 trials), "Behavioral" (4 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Relamorelin" (2 trials), "Aerobic Exercise" (1 trials), "Afternoon resistance exercise" (1 trials) and "Allopurinol" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Alberta Diabetes Institute
The vast majority of trials in "Alberta Diabetes Institute" are
8 trials for "All" genders and 3 trials for "Female" genders.
Clinical Trials Status at Alberta Diabetes Institute
Currently, there are NaN active trials in "Alberta Diabetes Institute".
undefined are not yet recruiting,
4 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Alberta Diabetes Institute,
undefined suspended trials,
and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Alberta Diabetes Institute, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 5 trials that are defined as “Not Applicable".